lunes, 29 de abril de 2013

WHO Pharmaceuticals Newsletter No. 2, 2013

Indice

Regulatory Matters
Azithromycin ................................................ 4
Denosumab ................................................... 4
Fingolimod ................................................... 4
Idebenone..................................................... 5
Laropiprant and niacin ...................................... 5
Lenalidomide ................................................. 6
Roflumilast .................................................... 6
Telaprevir ..................................................... 7
Tolvaptan ..................................................... 7


Safety of medicines
Cinacalcet ..................................................................... 8
Combined hormonal contraceptives ....................................... 8
Cyproterone- and ethinylestradiol-containing medicines................ 8
Incretin Mimetic Drugs for Type 2 Diabetes ............................... 9
Tetrazepam-containing medicines SOM .................................... 9


Signal
Febuxostat and Hepatic failure ............................................ 11
Propylthiouracil and Stevens-Johnson syndrome, Erythema multiforme
and Epidermal necrolysis ..................................................
13

Número completo disponible en